J E May|M M Frank - JoVE Visualize

Showing results (81-90 of 212) with videos related to

Pageof 22

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1983

Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytesE J Brown, J Ramsey, C H Hammer, et al.

Infection and Immunity|November 1, 1983

Classical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody moleculesE J Brown, M Berger, K A Joiner, et al.

Journal of Immunological Methods|May 4, 1987

Purification of C1 inhibitor. A new approach for the isolation of this biologically important plasma protease inhibitorL J Prograis, C H Hammer, K Katusha, et al.

Blood|November 1, 1980

Distribution of complement receptors on human normal and malignant mononuclear cellsR B Slease, J E Gadek, M M Frank, et al.

Annals of Internal Medicine|February 1, 1983

NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseasesM M Frank, T J Lawley, M I Hamburger, et al.

The Journal of Experimental Medicine|March 1, 1982

Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membraneK A Joiner, C H Hammer, E J Brown, et al.

Infection and Immunity|August 1, 1993

TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivityT A Russo, M C Moffitt, C H Hammer, et al.

The Journal of Experimental Medicine|September 1, 1985

IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111K A Joiner, L F Fries, M A Schmetz, et al.

Inflammation|June 1, 1987

Studies of phagocytosis in chronic granulomatous diseaseT A Gaither, S R Medley, J I Gallin, et al.

The Journal of Experimental Medicine|May 1, 1974

Ontogeny of B lymphocytes. II. Relative rates of appearance of lymphocytes bearing surface immunoglobulin and complement receptorsM C Gelfand, G J Elfenbein, M M Frank, et al.

Pageof 22

Showing results (81-90 of 212) with videos related to

Sort By:

Pageof 22

Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1983

Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytesE J Brown, J Ramsey, C H Hammer, et al.

Infection and Immunity|November 1, 1983

Classical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody moleculesE J Brown, M Berger, K A Joiner, et al.

Journal of Immunological Methods|May 4, 1987

Purification of C1 inhibitor. A new approach for the isolation of this biologically important plasma protease inhibitorL J Prograis, C H Hammer, K Katusha, et al.

Blood|November 1, 1980

Distribution of complement receptors on human normal and malignant mononuclear cellsR B Slease, J E Gadek, M M Frank, et al.

Annals of Internal Medicine|February 1, 1983

NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseasesM M Frank, T J Lawley, M I Hamburger, et al.

The Journal of Experimental Medicine|March 1, 1982

Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membraneK A Joiner, C H Hammer, E J Brown, et al.

Infection and Immunity|August 1, 1993

TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivityT A Russo, M C Moffitt, C H Hammer, et al.

The Journal of Experimental Medicine|September 1, 1985

IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111K A Joiner, L F Fries, M A Schmetz, et al.

Inflammation|June 1, 1987

Studies of phagocytosis in chronic granulomatous diseaseT A Gaither, S R Medley, J I Gallin, et al.

The Journal of Experimental Medicine|May 1, 1974

Ontogeny of B lymphocytes. II. Relative rates of appearance of lymphocytes bearing surface immunoglobulin and complement receptorsM C Gelfand, G J Elfenbein, M M Frank, et al.

Pageof 22